CD274 and breast carcinoma: Remarkably, PD-L1 was dramatically reduced in HITT-overexpressing human breast cancer cells (MDA-231, MDA-468, and BT549), mouse mammary cancer cells (4T1), cervical cancer cells (HeLa), and colon cancer cells (HT29) (Figure 2A and Supplemental Figure 1G).